Nsonaazụ Ọgwụgwọ Migraine dị ukwuu n'ụlọ

Teknụzụ CEFALY taa kwuputara nsonaazụ nke nyocha ụlọ ọgwụ na-egosi na ọgwụgwọ awa abụọ na ngwaọrụ e-TNS CEFALY bụ ihe dị mma ma dị irè, nke na-abụghị nke ọgwụ maka ọgwụgwọ siri ike nke mwakpo migraine na mpụga ụlọ ọgwụ.

Ọnwụnwa nke e-TNS maka ọgwụgwọ siri ike nke Migraine (TEAM) bụ nke mbụ, nke a na-atụ anya ya, onye kpuru ìsì abụọ, nke a na-ejighị n'aka, na-achịkwa ụlọ ọgwụ na-achịkwa nke 2-hour e-TNS ọgwụgwọ maka nnukwu migraine ọgụ na ụlọ. ndapụta. Ọmụmụ ihe TEAM bụkwa nke kachasị na-achịkwa sham, nyocha ụlọ ọgwụ na-enyocha iji ọgwụgwọ e-TNS ọ bụla maka ọgwụgwọ isi ọwụwa migraine.

Ọrịa akwara ozi na-emekarị ma na-agwụ ike, migraine ewerela ọkwa ụwa

Healthtù Ahụ Ike dị ka ihe na-akpata nkwarụ nke abụọ n'ụwa. Enwere oke ole na ole maka ọgwụ mgbochi isi ọwụwa. Na mgbakwunye, ọtụtụ ndị ọrịa na-ahọrọ ịzere ọgwụ iji gwọọ isi ọwụwa migraine ha. N'ihi ya, ihe ruru 40% nke ndị ọrịa migraine enweghị mkpa maka ọgwụgwọ migraine a.

Mpụga akwara trigeminal nke mpụga (e-TNS) bụ ọgwụgwọ ngwaọrụ ahụike nke na-enye usoro ọgwụgwọ na-abụghị nke ọgwụ, nke na-adịghị emerụ ahụ maka ndị ọrịa nwere migraine na-ahọrọ ịzere ọgwụ, nwere nnabata maka ọgwụ ma ọ bụ, chọrọ ọgwụgwọ mgbakwunye na njikwa migraine ha. A na-eyi n'egedege ihu, ngwaọrụ CEFALY e-TNS na-enye ọkụ eletrik dị nro iji belata mgbaàmà mgbu nke akwara trigeminal, ụzọ bụ isi maka mgbu migraine.

Ọmụmụ TEAM ahụ were ọnwa itoolu wee mee ya na ụlọ ọrụ iri n'ofe United States. Ọmụmụ ihe ahụ debanyere ndị ọrịa 10 dị afọ 538-18 nwere migraine episodic, na-enwe ma ọ bụ na-enweghị aura, bụ ndị nwere oke-na oke ike migraine ọgụ 65 ruo 2 ugboro kwa ọnwa. A na-ekenye ndị na-ahụ maka usoro ọmụmụ ihe niile n'enweghị usoro na verum ma ọ bụ òtù sham ma nye ha akwụkwọ akụkọ isi ọwụwa ma kụziere otu esi eji ngwaọrụ CEFALY.

N'ime oge ọnwa 2, a gwara ndị ọrịa ka ha na-ahụ maka ọgwụgwọ e-TNS n'onwe ha, dịka ọzụzụ na ntụziaka ha nwetara, n'ime awa 4 nke mmalite migraine ma ọ bụ n'ime awa 4 nke edemede na isi ọwụwa migraine. Ejiri ngwaọrụ CEFALY e-TNS tinye Neurostimulation maka oge awa 2, na-aga n'ihu.

N'ime otu verum, atụnyere otu sham:

• nnwere onwe mgbu na awa 2 bụ 7.2% elu (25.5% tụnyere 18.3%; p = .043)

• Mkpebi nke ihe mgbaàmà migraine na-enye nsogbu kachasị njọ bụ 14.1% elu (56.4% tụnyere 42.3%; p = 0.001)

• Mgbu mgbu na 2 awa bụ 14.3% elu (69.5% tụnyere 55.2%; p = 0.001)

• Enweghị ihe mgbaàmà niile metụtara migraine na awa 2 bụ 8.4% elu (42.5% tụnyere 34.1%; p = 0.044)

• nnwere onwe mgbu na-adịgide adịgide na mgbu mgbu na 24 awa bụ 7.0% na 11.5% dị elu na verum (22.8% na 45.9%) karịa sham (15.8 na 34.4%; p = 0.039)

Ọnweghị ihe ọjọọ dị njọ akọpụtaghị.

Ndị na-ede akwụkwọ kwubiri na iji ọgwụgwọ e-TNS nke awa 2 na-enye onwe ya bụ nhọrọ ọgwụgwọ dị mma ma dị irè, na-eji ma ọ bụ na-ejighị nnukwu ọgwụ mgbochi migraine.

“Ngwaọrụ CEFALY na-enye ndị ọrịa nhọrọ na-abụghị ọgwụ maka mgbochi na nnukwu ọgwụgwọ migraine. Ọ na-enye aka karịsịa ịgbakwunye na usoro ọgwụ ma ọ bụ iji ndị nwere ahụmahụ na-adịghị mma na ọgwụ migraine, "ka Dr. Deena Kuruvilla, otu n'ime ndị na-ede akwụkwọ na Medical Director na Board Certified Neurologist, Westport Headache Institute kwuru.

"Ọtụtụ ndị na-ebi na mgbu migraine na-achọsi ike maka ngwọta nke ha nwere ike iji n'enweghị nsogbu n'ụlọ," ka Jen Trainor McDermott, CEO nke CEFALY Technology kwuru. "Dịka ọmụmụ TEAM na-egosi anyị, CEFALY na-enye ihe mgbu dị ike, na-adịgide adịgide ha chọrọ."